NSE · BALAXI
BALAXI PHARMACEUTICALS LIMITED
₹23.99
-0.25%
Market Cap
132.44 Cr
P/E Ratio
92.27
P/B Ratio
0.53
ROE
0.57%
ROCE
3.35%
Dividend Yield
—
52W High
₹49.65
52W Low
₹23.01
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 |
|---|---|---|
| Revenue | 80.68 Cr | 70.71 Cr |
| Net Profit | 1.30 Cr | 61.28 L |
| EPS | 0.24 | 0.11 |
| Operating Profit | 2.82 Cr | 2.39 Cr |
Shareholding pattern
Promoter
65.99%
Public
34.01%
FII
—
DII
—
Recent corporate actions
No corporate actions on record for this stock.
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.